Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check3 days agoChange DetectedA new MedlinePlus Genetics related topic link for Prostate cancer was added under related topics, and the site revision label updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, signaling a new version of the study page. This appears to be a behind-the-scenes update rather than a substantive modification to the study content or results.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe Related Topics header and its links for Prostate cancer and MedlinePlus Genetics were removed, altering the page's navigation to related resources.SummaryDifference0.2%

- Check39 days agoChange DetectedAdded the topic tags 'Prostate cancer' and 'related topics: MedlinePlus Genetics' to enhance contextual linking, and updated the site revision label from v3.6.0 to v3.6.3.SummaryDifference0.2%

- Check54 days agoChange DetectedRemoved the 'Prostate cancer' tag and the 'MedlinePlus Genetics' related topics from the page. This changes how the study is categorized and surfaced in topic-based navigation and related links.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page received new user-help and navigation sections, including How to Read a Study Record, Common Questions, How to Join a Study, and related topic links. The Interventions label was standardized from 'Intervention / Treatment' to 'Intervention/Treatment' and a new site revision tag (Revision: v3.6.0) was added.SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.